Valuation Myriad Genetics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 23:00:00 24/07/2026 +03			5-day change	1st Jan Change
5.610 ^USD	-1.58%		-9.22%	-8.78%

07-20	Burning Rock Biotech Limited and Myriad Genetics Announce Global Strategic Technology Licensing Partnership to Expand Hrd Testing Worldwide	CI
07-02	Myriad Genetics Publishes Large-Scale Meta-Analysis Demonstrating Prognostic Performance of Prolaris Biopsy Test in Localized Prostate Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,204	1,176	1,697	1,248	573.3	529.9	-	-
Change	-	-46.65%	44.34%	-26.46%	-54.07%	-7.57%	-	-
Enterprise Value (EV)	1,864	1,061	1,595	1,185	543.6	529.9	529.9	529.9
Change	-	-43.09%	50.32%	-25.67%	-54.14%	-2.52%	0%	0%
P/E	-78.9x	-10.4x	-6.02x	-9.72x	-1.56x	-7.38x	-10.6x	-11.6x
PBR	2.28x	1.33x	2.2x	1.79x	1.56x	-	-	-
PEG	-	-0x	-0x	0.2x	-0x	0.1x	0.4x	1.37x
Capitalization / Revenue	3.19x	1.73x	2.25x	1.49x	0.7x	0.61x	0.58x	0.55x
EV / Revenue	0x	0x	0x	0x	0x	0.61x	0.58x	0.55x
EV / EBITDA	0x	-0x	-0x	0x	0x	14.4x	11.1x	9.95x
EV / EBIT	0x	-0x	-0x	0x	0x	46.1x	18.7x	10x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.35	-1.39	-3.18	-1.41	-3.95	-0.76	-0.53	-0.485
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	690.6	678.4	753.2	837.6	824.5	863.6	915.8	970.1
EBITDA ¹	71.9	-21	-6.3	40.4	38.9	36.81	47.81	53.23
EBIT ¹	9.1	-32.8	-25.5	21.8	15.1	11.48	28.31	52.9
Net income ¹	-27.2	-112	-263.3	-127.3	-365.9	-71.48	-50.98	-47.29
Net Debt	-339.8	-114.9	-102.4	-62.8	-29.7	-	-	-
Reference price ²	27.600	14.510	19.140	13.710	6.150	5.610	5.610	5.610
Nbr of stocks (in thousands)	79,855	81,034	88,669	91,035	93,214	94,448	-	-
Announcement Date	2/24/22 A	2/28/23 A	2/27/24 A	2/24/25 A	2/23/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MYRIAD GENETICS, INC.	-7.5x	-	-	-.--%	538M
GUARDANT HEALTH, INC.	-51.82x	15.62x	-114.29x	-.--%	19.92B
BIOMÉRIEUX	16.58x	1.88x	7.82x	1.56%	9.25B
LANTHEUS HOLDINGS, INC.	23.44x	4.4x	12.47x	-	6.75B
10X GENOMICS, INC.	-59.24x	9.16x	-77.95x	-.--%	6.1B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	20.49x	7.05x	15.91x	2.81%	5.53B
CARIS LIFE SCIENCES, INC.	159.26x	3.96x	25.94x	-.--%	4.42B
DIASORIN S.P.A.	19.28x	3.43x	10.67x	1.96%	4.03B
AUTOBIO DIAGNOSTICS CO., LTD.	16.15x	-	-	3.97%	2.71B
Average	15.18x	6.50x	-17.06x	1.29%	6.58B
Weighted average by Cap.	-2.47x	8.65x	-41.95x	0.93%